v3.26.3
Unaudited Consensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (14,327) $ (8,808) $ (12,199) $ (10,065)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 949 748 1,047 1,005
Amortization of finance lease right-of-use assets 90 109 211 226
Stock-based compensation expense 1,421 1,603 1,941 383
Non-cash operating lease expense 132 138 189 164
Non-cash finance lease interest expense 68 74 114 149
Deferred tax liability (42)    
Change in fair value of convertible notes     1,492
Change in operating assets and liabilities:        
Accounts receivable 139 798 764 (651)
Contract assets (215) (270) (100) 65
Prepaid expenses and other current assets (221) (112) 72 (76)
Other assets 5 (120) (120) (8)
Accounts payable 1,430 (102) 542 181
Accrued expenses and other current liabilities (194) 407 273 230
Operating lease liabilities 354 (94) (18) (164)
Contract liabilities 520 (232) (576) 562
Deferred tax assets     (29) 17
Net cash used in operating activities (9,891) (5,861) (7,889) (6,490)
Cash flows from investing activities:        
Purchases of property and equipment (1,712) (1,138) (2,008) (132)
Net cash flow used in investing activities (1,712) (1,138) (2,008) (132)
Cash flows from financing activities:        
Proceeds from issuance of Series A-2 preferred stock 9,990 10,000 11,410
Proceeds from issuance of Series X preferred stock 257 18,988
Payment of deferred offering costs (1,253) (45)
Proceeds from the exercise of stock options 92 87 89 4
Principal payment on finance leases (381) (250) (653) (471)
Proceeds from issuance of convertible note     1,150
Payment of issuance costs related preferred stock     (127) (485)
Net cash (used in) provided by financing activities (1,285) 9,827 28,252 11,608
Effect of exchange rate changes on cash (77) 150 28 44
Net (decrease) increase in cash (12,965) 2,978 18,383 5,030
Cash at beginning of year 27,967 9,584 9,584 4,554
Cash at end of period 15,002 12,562 27,967 9,584
Cash, end of period 15,002   27,967 9,427
Restricted cash, included in other assets, end of period     157
Total cash and restricted cash, end of period 15,002 12,562 27,967 9,584
Supplemental disclosure of cash flow information:        
Deferred offering costs in accrued expenses 2,746    
Reclassification of finance right-of-use asset to property and equipment upon purchase 298 442    
Cash paid for income taxes    
Operating lease right of use asset obtained in exchange for lease liabilities 296 1,441    
Finance lease right of use asset obtained in exchange for lease liabilities $ 879    
Supplemental disclosure of non-cash investing and financing activities:        
Property and equipment in accounts payable     5 122
Deferred offering costs in accounts payable and accrued expenses     813
Operating lease right of use asset obtained in exchange for lease liabilities     1,472
Reclassification of finance right-of-use asset to property and equipment upon purchase of leased equipment     442
Conversion of convertible notes into Series A-2 and Series SA-2 preferred stock     $ 13,528